Capecitabine: Advancing Tumor-Targeted Drug Delivery in P...
2026-01-19
Capecitabine, a potent fluoropyrimidine prodrug, empowers researchers to model tumor-specific drug activation and apoptosis within physiologically relevant assembloid and organoid systems. Its unique mechanism, selectivity enhancements, and robust workflow integration make it an essential tool for improving chemotherapy precision and unraveling resistance in preclinical oncology.